HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Fischer Selected Research

Formaldehyde (Formol)

11/2008Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1.
1/2008Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Fischer Research Topics

Disease

35Neoplasms (Cancer)
11/2022 - 12/2003
21Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2021 - 04/2003
15BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2021 - 01/2002
12Prostatic Neoplasms (Prostate Cancer)
02/2022 - 09/2002
11Leukemia
01/2019 - 01/2002
10Pain (Aches)
10/2021 - 12/2004
7Philadelphia Chromosome
10/2007 - 01/2002
6Disease Progression
12/2020 - 03/2002
6Lymphoma (Lymphomas)
01/2020 - 04/2005
5Multiple Myeloma
11/2021 - 09/2015
5Sepsis (Septicemia)
01/2019 - 08/2015
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017 - 09/2002
5Hematologic Neoplasms (Hematological Malignancy)
01/2017 - 08/2006
5Blast Crisis (Blast Phase)
04/2007 - 05/2002
4Hodgkin Disease (Hodgkin's Disease)
05/2016 - 07/2005
3Heart Failure
01/2022 - 12/2008
3Neoplasm Metastasis (Metastasis)
01/2022 - 12/2008
3Inflammation (Inflammations)
01/2022 - 01/2021
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2021 - 09/2014
3Residual Neoplasm
01/2021 - 01/2002
3Breast Neoplasms (Breast Cancer)
01/2021 - 03/2006
3Dementia (Dementias)
03/2019 - 11/2012
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2010 - 08/2006
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2022 - 01/2017
2Polycythemia Vera
05/2022 - 01/2022
2Venous Thrombosis (Deep-Vein Thrombosis)
03/2022 - 10/2018
2Splenomegaly
01/2022 - 12/2021
2Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2021 - 12/2005
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 01/2020
2Infections
02/2021 - 09/2015
2Delirium
01/2020 - 01/2019
2Arthritis (Polyarthritis)
06/2019 - 09/2017
2Thrombosis (Thrombus)
10/2018 - 11/2003
2Blister (Bulla)
11/2017 - 08/2013
2Carcinoma (Carcinomatosis)
08/2015 - 12/2008
2Joint Diseases (Joint Disease)
03/2010 - 01/2006
2Neuroblastoma
06/2009 - 02/2006
2Hemorrhage
12/2004 - 11/2003
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022

Drug/Important Bio-Agent (IBA)

18Imatinib Mesylate (Gleevec)FDA Link
02/2008 - 01/2002
10Phosphotransferases (Kinase)IBA
04/2022 - 01/2005
8Cytarabine (Cytosar-U)FDA LinkGeneric
12/2020 - 03/2003
7Proteins (Proteins, Gene)FDA Link
12/2022 - 10/2002
7Pharmaceutical PreparationsIBA
01/2021 - 05/2002
6AntigensIBA
01/2022 - 08/2015
6fms-Like Tyrosine Kinase 3IBA
01/2019 - 01/2005
6Monoclonal AntibodiesIBA
11/2008 - 04/2005
6bcr-abl Fusion ProteinsIBA
02/2008 - 02/2002
5Rituximab (Mabthera)FDA Link
12/2019 - 04/2005
5Prostate-Specific Antigen (Semenogelase)IBA
01/2019 - 09/2002
5Tyrosine Kinase InhibitorsIBA
01/2018 - 04/2003
4CytokinesIBA
03/2022 - 01/2017
3DNA (Deoxyribonucleic Acid)IBA
04/2022 - 09/2009
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 12/2010
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 12/2014
3Bortezomib (Velcade)FDA Link
11/2021 - 11/2017
3Contrast MediaIBA
01/2021 - 03/2010
3Dexamethasone (Maxidex)FDA LinkGeneric
11/2017 - 12/2010
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2017 - 12/2005
3Anti-Bacterial Agents (Antibiotics)IBA
09/2009 - 02/2005
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2008 - 06/2006
3Interferon-alpha (Interferon Alfa)IBA
02/2008 - 03/2003
2Complement System Proteins (Complement)IBA
11/2022 - 09/2015
2Type II Tumor Necrosis Factor ReceptorsIBA
05/2022 - 12/2021
2Type I Tumor Necrosis Factor ReceptorsIBA
05/2022 - 12/2021
2IntegrinsIBA
03/2022 - 10/2018
2Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2020
2Interleukin-12 (IL 12)IBA
12/2021 - 01/2017
2tyrosine receptor (receptor, tyrosine)IBA
09/2021 - 07/2007
2Chemokine ReceptorsIBA
02/2021 - 01/2008
2Analgesics (Analgesic Drugs)IBA
01/2020 - 03/2019
2Matrix Metalloproteinases (MMPs)IBA
06/2019 - 03/2016
2MicroRNAs (MicroRNA)IBA
01/2019 - 12/2008
2Indicators and Reagents (Reagents)IBA
10/2016 - 02/2006
2Vincristine (Oncovin)FDA LinkGeneric
08/2016 - 12/2005
2Prednisone (Sone)FDA LinkGeneric
08/2016 - 12/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2016 - 12/2005
2Radioisotopes (Radionuclides)IBA
01/2016 - 08/2015
2midostaurinIBA
10/2010 - 01/2006
2PanobinostatIBA
10/2009 - 08/2006
2Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
06/2009 - 02/2006
2ParaffinIBA
11/2008 - 01/2008
2Formaldehyde (Formol)FDA Link
11/2008 - 01/2008
2FibrinIBA
11/2003 - 10/2002
1AZD1390IBA
04/2022
12- (2,6- dimethylmorpholin- 4- yl)- N- (5- (6- morpholin- 4- yl- 4- oxo- 4H- pyran- 2- yl)- 9H- thioxanthen- 2- yl)acetamideIBA
04/2022

Therapy/Procedure

30Therapeutics
02/2022 - 05/2002
16Drug Therapy (Chemotherapy)
01/2022 - 04/2003
11Stem Cell Transplantation
06/2021 - 01/2002
6Radiotherapy
12/2022 - 03/2015
5Central Venous Catheters
01/2019 - 08/2015
4Home Nursing (Nursing, Home)
10/2021 - 10/2011
4Aftercare (After-Treatment)
02/2021 - 10/2005
3Immunotherapy
04/2022 - 04/2005
3Pain Management
10/2021 - 05/2005
3Homologous Transplantation
11/2019 - 01/2002
2Prostatectomy (Retropubic Prostatectomy)
01/2017 - 04/2016
2Intravenous Administration
10/2010 - 03/2010
2Hematopoietic Stem Cell Transplantation
06/2007 - 09/2003
1CT protocol
11/2022